Fluormisonidazole and fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: A feasibility study

被引：0
|
作者：
Gagel, B
Reinartz, P
Piroth, M
Pinkawa, M
Kaiser, HJ
Asadpour, B
Eble, MJ
机构：
[1] Univ Klinikum, Rhein Westfal TH Aachen, Klin Strahlentherapie, Aachen, Germany
[2] Univ Klinikum, Rhein Westfal TH Aachen, Klin Nukl Med, Aachen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2005年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] MEDIASTINAL STAGING OF NON-SMALL-CELL LUNG-CANCER WITH POSITRON EMISSION TOMOGRAPHY
    CHIN, R
    WARD, R
    KEYES, JW
    CHOPLIN, RH
    REED, JC
    WALLENHAUPT, S
    HUDSPETH, AS
    HAPONIK, EF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) : 2090 - 2096
  • [22] Use of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography after Curative Treatment of Non-Small-Cell Lung Cancer Patients: A Nationwide Cohort Study
    Guldbrandsen, Kasper Foged
    Sopina, Liza
    Rasmussen, Torben Riis
    Fischer, Barbara Malene
    DIAGNOSTICS, 2024, 14 (02)
  • [23] Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer
    Tanvetyanon, Tawee
    Eikman, Edward A.
    Sommers, Eric
    Robinson, Lary
    Boulware, David
    Bepler, Gerold
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4610 - 4616
  • [24] Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients
    Wu, Yihua
    Li, Peiwei
    Zhang, Honghe
    Shi, Yu
    Wu, Han
    Zhang, Jinjie
    Qian, Yufeng
    Li, Chao
    Yang, Jun
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : E37 - E47
  • [25] The Registration of Diagnostic versus Planning Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Radiotherapy Planning for Non-small Cell Lung Cancer
    Yap, Mei L.
    Vinod, S. K.
    Shon, I. A. Ho
    Fowler, A.
    Lin, M.
    Gabriel, G.
    Holloway, L. C.
    CLINICAL ONCOLOGY, 2010, 22 (07) : 554 - 560
  • [26] Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?
    Patz, Edward F., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4542 - 4543
  • [27] Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer
    Skoura, Evangelia
    Datseris, Ioannis E.
    Platis, Ioannis
    Oikonomopoulos, Georgios
    Syrigos, Konstantinos N.
    CLINICAL LUNG CANCER, 2012, 13 (03) : 181 - 187
  • [28] Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: A review
    Pillot, Giancarlo
    Siegel, Barry A.
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 152 - 159
  • [29] Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography
    Lardinois, D
    Weder, W
    Hany, TF
    Kamel, EM
    Korom, S
    Seifert, B
    von Schulthess, GK
    Steinert, HC
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25): : 2500 - 2507
  • [30] Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer
    Taylor, Matthew D.
    Smith, Philip W.
    Brix, William K.
    Wick, Mark R.
    Theodosakis, Nicholas
    Swenson, Brian R.
    Kozower, Benjamin D.
    Lau, Christine L.
    Jones, David R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (01): : 43 - 48
12345